Bosnia and Herzegovina on Wednesday received the final shipment of more than 18,000 Pfizer vaccines against Covid-19 through the European Union platform EU4Health, and on Thursday received 100,620 doses of the same manufacturer through the COVAX system.
The information was confirmed by Assistant Minister of Civil Affairs Dushan Koji.
Accompanied by the Directorate for Coordination of Police Bodies of Bosnia and Herzegovina, 100,630 Pfizer doses arrived in the country. “The safe and fast arrival of vaccines is important, especially in the case of this manufacturer’s temperature regime,” Kojic said on Twitter on Thursday.
The EU Delegation to BiH announced on Wednesday that the final batch of 18,720 Pfizer / BioNTech vaccines procured from Bosnia and Herzegovina under a € 13.7m EU4Health grant arrived in Sarajevo. “This brings the total number of Pfizer / BioNTech vaccines delivered to assist Bosnia and Herzegovina in its fight against the Covid-19 pandemic under this EU4Health grant in 214,110 doses,” the EU Delegation said.
Of the € 13.7 million allocated under EU4Health to support vaccination against Covid-19 in Bosnia and Herzegovina, more than € 9 million remains to support further vaccine purchases. The EU will continue to work with the Ministries of Civil Affairs of Bosnia and Herzegovina and other authorities to facilitate further deliveries.
The EU and its member states (Team Europe) have so far delivered a total of 1,302,110 doses of vaccine to Bosnia and Herzegovina to provide protection against Covid-19. These donations are supporting Bosnia and Herzegovina to increase its vaccination campaign and increase the number of fully vaccinated persons.
Today’s vaccine delivery is part of a commitment of 650,000 EU-funded Pfizer / BioNTech vaccines destined for Albania, Bosnia and Herzegovina, Kosovo, Montenegro, Serbia and Northern Macedonia. The final groups of this package arrived at their destinations this week. The delivery of these vaccines was facilitated by the Republic of Austria, through legal agreements with the manufacturer and the authorities in the region.